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OBJECTIVES To investigate the potential for plant derived estrogens (phytoestrogens) genistein, phloretin,
biochanin A and zearalanone to relax rabbit coronary arteries in vitro and to determine the
mechanism(s) of such relaxation.
BACKGROUND Epidemiological data suggests a reduction in the incidence of coronary heart disease in
humans who have a high intake of phytoestrogens.
METHODS Isolated rabbit coronary artery rings were suspended in individual organ baths, precontracted
with potassium chloride (30mM), and the relaxing effects and mechanisms of relaxation to
genistein, phloretin, biochanin A and zearalanone were determined by measurement of
isometric tension.
RESULTS Genistein, phloretin and biochanin A induced significant gender-independent relaxation in
rings with and without endothelium. Inhibition of nitric oxide and prostaglandin synthesis
with L-NAME and indomethacin had no effect on genistein-induced relaxation. Relaxation
was unaffected by the specific estrogen receptor antagonist ICI 182,780, the ATP-sensitive
potassium channel inhibitor glibenclamide and the potassium channel inhibitor, barium
chloride. Calcium concentration-dependent contraction curves in high potassium depolar-
ization medium were significantly shifted to the right and downward after incubation with
genistein and zearalanone. An inhibitory effect of genistein (2 mM) on L-type calcium current
in guinea-pig ventricular myocytes confirmed a calcium antagonist relaxing mechanism of
action. In healthy volunteers, plasma genistein levels of approximately 2 mM are achieved
after ingestion of a commercially available soy protein drink (Supro) containing 37 mg
genistein.
CONCLUSIONS This study demonstrates that phytoestrogens induce endothelium-independent relaxation of
coronary arteries; the mechanism involves calcium antagonism. These mechanisms may
contribute to the potential long-term cardiovascular protective effect of these substances. (J
Am Coll Cardiol 2000;35:1977–85) © 2000 by the American College of Cardiology
Phytoestrogens are synthesized by all plants, particularly soy
beans, and possess estrogenic activity in animals (1–6).
Phytoestrogens are naturally found in many foods and they
are defined as plant substances that are structurally or
functionally similar to estradiol. They consist of a number of
classes, including lignans, isoflavones, coumestans and res-
orcyclic acid lactones. Lignans and isoflavones have been
detected in humans and both have been shown to have
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biological activity in man and animals (7). The human diet
provides the precursors for the formation of mammalian
ligans and isoflavones. The highest concentration of ligans
are found in oil seeds, cereal bran, whole cereals, vegetables,
legumes and fruits (8). The isoflavones are less widely
distributed in plant foods, but they do occur in high
concentration in soy beans, chick peas and other legumes as
well as toothed medic, bluegrass and clovers (9). A more
complete review of the clinical effects of phyto-oestrogens
has been published (10). Lignans and isoflavones are derived
from dietary precursors largely by gut flora. The major
isoflavones found in humans, namely diadzein and genistein
are derived from formonentin and biochanin A, respectively.
As well as evidence that ovarian estrogens have cardio-
vascular protective effects (11,12), there is evidence that
dietary phytoestrogens may also confer cardiovascular pro-
tection. Epidemiological data suggest a reduction in the
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incidence of coronary heart disease in humans who have a
high intake of phytoestrogens (13,14). Increased plasma
levels of the phytoestrogen genistein are suggested as an
explanation for the infrequency of hot flashes and meno-
pausal symptoms in Japanese women (15).
There are structural similarities between the steroidal
nucleus of 17beta-estradiol and the rigid ring structure of
phytoestrogens. Flavanoids are compounds containing a
characteristic aromatic trimeric heterocyclic nucleus, usually
occurring in glycosidic form and widely distributed in
plants. Using competitive binding techniques between
17beta-[3H] estradiol and the estrogen receptor in cell-free
extracts, it was shown that hydroxylated flavanoids (includ-
ing chalones [isoliquiritigenin, phloretin], isoflavones
[genistein], flavones [apipenin] and flavonones) interact
directly with the estrogen receptor (16). Genistein has
vascular activity and can attenuate acetylcholine (ACh)-
induced coronary vasoconstriction in atherosclerotic cyno-
molgus monkeys in a very similar way to estrogen (17),
which may imply a stimulatory effect on the nitric oxide
pathway.
The mechanism involved in coronary artery vasodilation
may also contribute to the cardioprotective effects of estro-
gen (18–21). Despite the increasing interest in the effects of
phytoestrogens on the cardiovascular system, it is unknown
whether they share the coronary artery vasodilator proper-
ties of estrogen. We, therefore, investigated the vascular
effects of the phytoestrogens genistein, phloretin, biochanin
A and zearalanone in rabbit coronary arteries and isolated
cardiac myocytes in vitro.
METHODS
Animals and tissues. Adult male or nonpregnant female
New Zealand white rabbits (2.5–3 kg) were killed by an
overdose of pentobarbitone (60 mg kg21 and heparin
(150 U kg21). The heart was removed and epicardial
coronary arteries were dissected free of connective tissue.
Arterial rings were prepared and, in some rings, the endo-
thelium was removed by gentle rubbing with a wooden
probe. Each ring (2–3 mm length) was suspended horizon-
tally between two stainless steel parallel hooks for the
measurement of isometric tension in individual organ baths
containing 10 ml modified Krebs solution at 37° C, bubbled
with 95% O2 and 5% CO2. The composition of modified
Krebs solution was as follows (mM): NaCl, 118.3; KCl, 4.7;
CaCl2, 2.5; MgSO4, 1.2; K2PO4, 1.2 and glucose, 11.1.
Coronary arterial rings with or without endothelium from
male and female rabbits were allowed to stabilise for 90 min
under a resting tension of 1 g (9.8 mN) before being
contracted. Preparations were exposed to maximally effec-
tive concentrations of a contractile agonist (K1, 30 mM) to
ensure stabilization of the rings. The agonist was then
removed and the ring reequilibrated. The presence or
absence of endothelium was always verified by observing the
relaxation response to acetylcholine (ACh).
Effect of phytoestrogens on precontracted coronary ar-
teries. Coronary arterial rings with or without endothelium
were contracted with K1 (30 mM). Increasing concentra-
tions of the phytoestrogens genistein (10, 20 and 40 mM),
phloretin (5, 10, 20 and 40 mM) or biochanin A (3, 10 and
30 mM) were added at half-log increments at the plateau of
the previous response. The response at each concentration
of phytoestrogen was measured. Simultaneous time-
matched ethanol control curves were constructed using an
equivalent volume of solvent as that used to dissolve the
phytoestrogen.
Comparative relaxing effects of genistein in the presence
of a variety of inhibitors. In experiments where specific
inhibitors were used, they were added 20 min before precon-
tarction with 30 mM KCl. Responses to genistein (1–40 mM)
were then measured. The inhibitors tested were Nomega-nitro-
L-arginine methyl ester (L-NAME—0.1 mM) an inhibitor of
NO synthesis from L-arginine in vascular endothelial cells
(22) and indomethacin (10 mM), an inhibitor of prostanoid
synthesis (23). To examine the possible role of potassium
conductance on flavanoid-induced coronary relaxation, glib-
enclamide (3 mM), an ATP-sensitive potassium channel
inhibitor, and barium chloride, a nonspecific inhibitor of
potassium channels (24). To examine the possible role of
the classical estrogen receptor in mediating phytoestrogen-
induced relaxation, rings with and without endothelium
were incubated in the specific estrogen receptor antagonist
ICI 182,780 (25) (10 mM). Rings without endothelium
were incubated in methylene blue (10 mM) to determine the
role of cGMP in the relaxant effect of genistein (26).
Effect of phytoestrogens on calcium concentration re-
sponses in rabbit coronary arteries. Rabbit coronary arte-
rial rings without endothelium were incubated in calcium-
free solution containing 0.5 mM EGTA for 10 min. The
calcium concentration-dependent contraction curves were
then performed in high K1 depolarization medium
(100 mM). Rings were readjusted in modified Krebs for
20 min and then incubated in calcium-free solution con-
taining EGTA (0.5 mM) for a further 10 min. Subsequently
rings were incubated with genistein (20 and 40 mM) or
zearalanone (1 and 10 mM). The calcium concentration-
dependent contraction curves were then repeated.
Comparative relaxing effects of phytoestrogens on pre-
contracted coronary arteries. The relaxing effects of an
equal concentration (10 mM) of genistein, phloretin and
Abbreviations and Acronyms
ACh 5 acetylcholine
HEPES 5 hydroxyethyl pipirazine-ethanesulphonic
acid
ICa 5 L-type calcium current
L-NAME 5 Nomega-nitro-L-arginine methyl ester
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biochanin A on coronary arterial rings contracted with K1
(30 mM) was determined.
Electrophysiological experiments. Electrophysiological
experiments were performed on isolated left ventricular
myocytes from adult male guinea-pigs prepared by enzy-
matic dissociation as previously described (27). Animals
were heparinized and killed by cervical dislocation, the heart
rapidly removed, the aorta cannulated and the heart retro-
gradely perfused on a Langendorff apparatus with normal
Tyrode solution at 37°C before enzymatic digestion. The
composition of normal Tyrode was as follows (mM): NaCl
140, KCl 6, CaCl 2, MgCl 1, Glucose 10, hydroxyethyl-
pipirazine-ethanesulphonic acid (HEPES) 10, titrated to
pH 7.4 with 2M NaOH. The isolated cells were stored in
Dulbecco’s medium (Gibco) at room temperature.
Cells were allowed to settle for up to 5 min on the glass
base of a low volume (20 ml) plexiglass superfusion chamber
mounted on the stage of an inverted microscope after
applying ’1 ml mouse laminin (Gibco) to the base of the
chamber. Normal Tyrode (NT) at room temperature was
carried to the chamber by means of gas impermeable tubing
at ’2.5 ml/min, and at this rate solution switching was
complete within 4 s. Genistein was added from a 40 mM
stock solution in ethanol. Borosilicate glass microelectrodes
with resistances of 20 to 35 M omego to minimize intra-
cellular dialysis were filled with a solution of 2M KCl,
5 mM HEPES and 100 nM EGTA at pH 7.2.
Electrophysiological recordings were made with an
Axoclamp-2A amplifier controlled by pClamp6 software,
which was also used for data analysis (Axon Instruments).
Action potentials were recorded by stimulating the cells in
current clamp mode with a 1 nA pulse of 10 ms duration.
Voltage clamp experiments were performed in switch clamp
mode (discontinuous single electrode voltage clamp,
5–6 kHz) with gains between 0.3 and 0.8 nA/mV, maxi-
mized to obtain sharp voltage steps without oscillation.
Membrane current was filtered at 0.1 kHz, digitized at 5
kHz and analyzed as the average of five consecutive record-
ings. L-type calcium current (ICa) was measured as the
difference between the nifedipine sensitive, time-dependent
peak inward current and the steady-state current present at
the end of a 400 ms clamp step. Cell shortening was
measured at one cell edge with a video detection system.
Human volunteer study to determine plasma levels of
ingested genistein. Fourteen male volunteers ingested a
commercially available isolated soy protein milk beverage
Supro or placebo (Protein Technologies International, St.
Louis, Missouri) on three occasions, on day one at 7:00 AM
and 7:00 PM and on day two at 7:00 AM. A blood sample was
taken on day two at 11:00 AM, 4 h after the ingestion of the
last soy protein drink. The volunteers were asked not to
consume soy protein containing foods, such as tofu or drinks
such as beer during the time of the study and for 24 h before
the first ingestion. Supro contains 60 mg of isoflavones,
37 mg of which is genistein. The mucosal lining of the gut
is necessary for the activation of genistein in this form and
activation takes approximately 3 to 5 h. The study was a
randomized, double blind study and was placebo-controlled.
The placebo contained no phytoestrogens. Blood samples
were taken before the first ingestion and 4 h after the third
ingestion of either placebo or active Supro. Plasma levels
of genistein were measured by isotope dilution gas
chromatography-mass spectroscopy by a group experienced
in these measurements (Dr. M. Morton, Tenovus Cancer
Research Center, University of Wales College of Medicine,
Cardiff, United Kingdom).
Drugs. The following drugs were used: genistein (Sigma—
soy source); phloretin (Sigma); biochanin A (Sigma); zear-
alanone (Sigma); Nomega-nitro-L-arginine methyl ester
(Sigma); indomethacin (Sigma); glibenclamide (ICN); ICI
182,780 (a gift from Zenica Pharma, Cheshire, United
Kingdom); Supro or placebo (Protein Technologies Inter-
national, St Louis, Missouri).
Data analysis. All results are expressed as mean 6 SEM.
Relaxation is expressed as percentage relaxation of contrac-
tion induced by K1 (30 mM). The results were analyzed
with analysis of variance, and the Student-Newman-Keuls
test was used for multiple comparisons. A probability level
of less than 0.05 was considered significant. The number of
animals is indicated by “n,” unless indicated otherwise.
RESULTS
Relaxing effect of phytoestrogens on precontracted cor-
onary arteries. K1 (30 mM) induced significant contrac-
tion, comparable in rings with or without endothelium
(8.5 6 0.9 and 7.6 6 0.6 mN; p . 0.05). Genistein (Figs.
1 and 4), phloretin (Fig. 2) and biochanin A (Fig. 3)
Figure 1. Bar graph showing the relaxing effect of genistein (10,
20 and 40 mM) on rabbit coronary artery rings with (n 5 6) and
without endothelium (n 5 6). Rings were precontracted with K1
(30 mM). Data are expressed as percentage relaxation of contrac-
tion induced by K1 (mean 6 SEM). Control indicates a time-
matched equivalent volume of solvent (n 5 12–14). *indicates
significant differences in comparison with control; * 5 p , 0.05; **
5 p , 0.01; *** 5 p , 0.001.
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induced significant relaxation of contracted rings compared
with time-matched controls in a concentration-dependent
manner. There were no significant differences in relaxation
between arteries from male or female rabbits (n 5 6; p .
0.05) or between rings with or without endothelium (n 5 6;
p . 0.05). The same concentration (10 mM, n 5 6) of
phytoestrogens relaxed precontracted coronary arteries with
different potencies. The order of potency was biochanin
A . phloretin . genistein (Fig. 5).
Effect of the presence of a variety of inhibitors on
genistein-induced relaxation. Incubation with the inhib-
itor of NO synthesis, L-NAME, or the inhibitor of prosta-
noid synthesis, indomethacin, (all n 5 6) did not inhibit
relaxation induced by genistein in rabbit coronary arterial
rings with endothelium (Fig. 6a). Incubation in ICI
182,780, an estrogen-receptor antagonist, did not affect the
relaxation induced by genistein in rings with endothelium
(Fig. 6a). Blockade of the ATP-sensitive potassium channel
inhibitor glibenclamide and the nonspecific inhibitor of
potassium channels barium chloride had no effect on relax-
ation induced by genistein in rings without endothelium
(Fig. 6b). Methylene blue had no effect on relaxation
induced by genistein, phloretin or biochanin A in rings
without endothelium (Fig. 6b).
Calcium antagonistic effects of genistein and zearal-
anone on rabbit coronary arterial rings. The calcium
concentration-dependent contraction curves in high K1
(100 mM) depolarization medium were shifted to the right
after incubation with genistein (20 and 40 mM, n 5 6) and
zearalanone (1 and 10 mM, n 5 6) in rings without
endothelium compared with control. Maximal contraction
was also reduced (Fig. 7, a and b).
Inhibitory effect of genistein on ICa. To further investi-
gate the effects of phytoestrogens on calcium dependent
contraction, ICa was measured directly in calcium tolerant,
healthy guinea-pig ventricular myocytes with resting mem-
brane potentials of #270 mV isolated from six hearts. Cells
were held under voltage clamp at 240 mV to inactivate fast
sodium current and calcium current elicited by applying
400 ms clamp steps to 0 mV at a frequency of 0.5 Hz.
Results are demonstrated in Figure 8. Panel A demon-
Figure 2. Bar graph showing the relaxing effect of phloretin (5, 10,
20 and 40 mM) on rabbit coronary artery rings with (n 5 6) and
without (n 5 6) endothelium. Rings were precontracted with K1
(30 mM). Data are expressed as percentage relaxation of contrac-
tion induced by K1 (mean 6 SEM). Control indicates a time-
matched equivalent volume of solvent (n 5 12–14). *indicates
significant differences in comparison with control; * 5 p , 0.05; ***
5 p , 0.001.
Figure 3. Bar graph showing the relaxing effect of biochanin A (3,
10 and 30 mM) on rabbit coronary artery rings with (n 5 6) and
without endothelium (n 5 6). Rings were precontracted with K1
(30 mM). Data are expressed as percentage relaxation of contrac-
tion induced by K1 (mean 6 SEM). Control indicates a time-
matched equivalent volume of solvent (n 5 12–14). *indicates
significant differences in comparison with control; * 5 p , 0.05; **
5 p , 0.001.
Figure 4. Original tracing demonstrating genistein (10, 20 and
40 mM)-induced relaxation in K1-contracted coronary arterial
rings.
Figure 5. Comparison of the relaxant effects of equivalent concen-
trations (10 mM) of genistein, phloretin and biochanin A.
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strates the reduction in steady state peak ICa accompanied
by reduced cell contraction, 1 min after superfusion with
2 mM genistein. Peak ICa was found to be reduced from
2491 6 37 pA to 2248 6 37 pA (p , 0.001, n 5 12) with
a reduction in cell contraction from 2.1 6 0.3 mm to 0.7 6
0.2 mm (p , 0.001, n 5 12). Current-voltage and
contraction-voltage curves were constructed with 400 ms
clamp steps to varying potentials from a holding potential of
240 mV at a frequency of 0.5 Hz as shown in panel B.
Inhibition of ICa occurred over the range of potentials
tested, but the shape of the curve was not affected by
genistein with peak ICa and contraction occurring between
0 and 10 mV. The effect of genistein was dose-dependent
with, most notably, complete abolition of isolated cell
contraction at the highest concentration of 40 mM. The
histograms in panel C were constructed by superfusing with
increasing concentrations of genistein and measurements
made at steady state, 90 s after each solution switch.
Reversibility of genistein effect. On returning to superfu-
sion with NT and with continued stimulation under voltage
clamp steps, there was partial recovery of ICa and cell
contraction over the first minute to 2292 6 39 pA (p ,
0.05) and 0.9 6 0.3 mm (p , 0.01), respectively (n 5 11).
No further recovery was observed over an additional 3 min.
The original trace in panel A was taken from one of a
series of experiments where peak ICa was remeasured after a
train of stimulated action potentials in current clamp mode
after washout of genistein. Under these conditions, ICa
demonstrated full recovery to 2487 6 122 (p 5 0.8,
compared with control, n 5 4) with recovery of cell
contraction to 1.0 6 0.5 mm (control: 1.4 6 0.4 mm, p 5
0.27, n 5 4).
Human volunteer study—plasma genistein levels. Seven
volunteers (age 33 6 4 years) received placebo and seven
volunteers (age 42 6 5 years, NS placebo vs. active) received
the active Supro drink. In the seven volunteers who received
placebo, the baseline genistein levels were 0.02 mM 6
0.01 mM, and after placebo the levels were 0.04 mM 6
0.05 mM (p 5 NS).
In the active Supro group, the baseline genistein levels
were 0.03 mM 6 0.02 mM. After receiving active Supro, the
genistein levels were 2.1 mM 6 0.8 mM (p , 0.0007,
placebo vs. active Supro).
DISCUSSION
We have shown that the phytoestrogens genistein, phlor-
etin, biochanin A and zearalanone induce significant relax-
ation of coronary artery rings. Relaxation was dose-
dependent. No difference was observed between rings with
or without endothelium or between rings from male versus
those from female rabbits. Preincubation with L-NAME,
indomethacin, glibenclamide, barium chloride or methylene
blue did not affect genistein-induced coronary artery relax-
Figure 6. (a) The effect of incubation in L-NAME (L-NA), ICI
182,780 (ICI) and indomethacin (Indometh) on genistein-induced
relaxation in rings with endothelium compared with control rings
(no incubation) (n 5 6, p . 0.05). (b) The effect of incubation in
barium chloride (BaCl), glibenclamide (Gliben) and methylene
blue (Methyl blue) on genistein-induced relaxation in rings with-
out endothelium compared with control rings (no incubation) (n 5
6, p . 0.05).
Figure 7. The effect of genistein (Ge: 20 and 40 mM) (a) and
zearalenone (Zea; 1 and 10 mM) (b) on the calcium concentration-
dependent contraction curves in rabbit coronary arteries without
endothelium compared with control. Data are expressed as per-
centage of maximal contraction induced by calcium in controls
(mean 6 SEM). *indicates significant differences in comparison
with corresponding controls; * 5 p , 0.05; ** 5 p , 0.01; *** 5
p , 0.001.
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ation. Similarly, the specific estrogen receptor antagonist
ICI 182,780 did not affect the coronary relaxation induced
by genistein. Incubation with both genistein and zearal-
anone shifted the calcium concentration-dependent con-
traction curve to the right and reduced the maximal con-
traction.
Figure 8. The effects of genistein on calcium current and contraction of isolated guinea-pig cardiac myocytes. (A) Averaged traces from
a representative cell on repetitive step depolarizations from a holding potential of 240 mV to 0 for 400 ms. (i) Control in normal Tyrode,
(ii) after 1 min stabilization in 2 mM genistein, (iii) after washout in normal Tyrode and a period of action potential stimulation under
current clamp. (B) (i) Current-voltage and (ii) contraction-voltage relationships in normal Tyrode (open circle) and 2 mM genistein (solid
circle) with step depolarizations of 400 ms from a holding potential of 240 mV (n 5 9 unless indicated otherwise). (C) Dose-response
relationships for (i) L-type calcium current and (ii) contraction after 90 s in varying concentrations of genistein (n indicated for each bar).
In all cases, data are expressed as mean 6 SEM. * indicates p , 0.05; ** indicates p , 0.01; *** indicates p , 0.001 compared with control.
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Calcium antagonist mechanism of relaxation. The find-
ing that incubation with genistein or zearalenone shifted the
calcium concentration-dependent contraction curve to the
right in high K1 depolarization medium suggests that these
phytoestrogens are acting via a calcium antagonistic mech-
anism to cause relaxation of coronary arteries. This is similar
to estrogen and progesterone (18,28,29). Influx of calcium is
known to be an important mediator of excitation-
contraction coupling in smooth muscle cells. Thus, the
inhibition of calcium influx may be an important mecha-
nism of the action of genistein. Though the maximal
contraction curves to the right in a parallel fashion would
suggest that phytoestrogens interfere with calcium influx
through the voltage-operated calcium channel. The most
potent relaxation was induced by biochanin A followed by
phloretin then genistein. The mechanism of this differential
effect on coronary artery relaxation was not determined, but
a structure-function relationship is a possibility.
A calcium antagonist action of genistein was proven by
demonstrating that it reversibly inhibited L-type calcium
current and contraction in isolated guinea-pig ventricular
myocytes in a concentration-dependent manner. We have
previously shown a similar effect of 17beta-estradiol (28). At
40 mM genistein, the highest concentration evaluated,
isolated cell contraction was abolished as the result of
inhibition of peak ICa to 6% of control. This mirrored the
total relaxation of precontracted coronary rings exposed to
the same concentration. These results are consistent with a
calcium antagonistic mechanism for phytoestrogen-induced
vasodilatation. Importantly, the degree of ICa inhibition
observed with 2 mM genistein is comparable with that likely
to be occurring with “calcium antagonists” at clinically
relevant doses (30,31).
Complete recovery of ICa did not occur until membrane
potential was restored and action potentials were stimulated.
This might reflect analogous behavior to that of ‘calcium
antagonists’ whose affinity for the inactivated state of the
L-type channel exceeds that for the resting state. At
240 mV, 20% of the channels remain inactivated, thus
delaying dissociation of genistein (31). This question has
not been directly addressed for phytoestrogens, but the
relationship holds true for 17beta-estradiol (28).
Other potential mechanisms of vascular relaxation by
phytoestrogens. The phytoestrogen genistein is a tyrosine
kinase inhibitor (32–34). The concentrations of genistein
that induced vascular smooth muscle relaxation are within
the inhibitor concentration values for genistein against
tyrosine protein kinases (2.6–26 mM). However, the relax-
ant effect of genistein via inhibition of tyrosine kinase
activity depends very much on the specific agonist used to
induce contraction (35–37). Tyrosine kinase inhibitors re-
versibly inhibit alpha-adrenergic and muscarinic receptor-
mediated contraction. In contrast, genistein only causes
slight inhibition of contraction elicited by potassium-
induced depolarization in guinea pig taenia coli, mesenteric
microvessels and canine carotid arteries. Thus, the demon-
stration of almost complete relaxation (.99%) in this study
in coronary arteries precontracted by depolarization with
K1 (30 mM) suggests that mechanisms other than tyrosine
kinase inhibition are responsible for coronary artery relax-
ation in this preparation. The concentrations of genistein
that have been shown to relax coronary arteries and inhibit
calcium current in isolated myocytes (2 mM) in this study
are equivalent to plasma concentrations measured in the
volunteer study. These data, therefore, support the fact that
the mechanisms demonstrated in vitro may result in cardio-
vascular actions in vivo in humans.
Neither endothelium-derived nor prostaglandins appear
to be involved in the coronary artery relaxing effect of
phytoestrogens because their respective inhibitors, namely
L-NAME and indomethacin, had no effect on the relaxing
response to genistein.
The classical estrogen receptor (ERalpha) has been found
in arterial smooth muscle cells, including coronary arteries,
of several mammalian species (38,39). Phytoestrogens have
been shown to interact with the ERalpha (4,16,40) although
this has not been demonstrated in rabbit coronary arter-
ies. The possible involvement of ERalpha in genistein-
induced coronary artery relaxation was tested using the
specific ER antagonist ICI 182,780 (7 alpha-[9-(4,4,5,5,-
pentafluoropentylsulfinyl)nonyl]estra-1,3,5(10)-triene-
3,17beta-diol) (25). The lack of inhibition of ICI 182,780
of the relaxant effects of genistein suggests that the ERalpha
does not play a role in the acute vasorelaxant effects of
genistein in coronary arteries in vitro. Our data support a
non-receptor mechanism of relaxation of vascular smooth
muscle by genistein. However, our data do not preclude
actions of dietary genistein (plasma levels approximate
1 mM [41]) on the ER, for which it has a relatively high
affinity (Ki 5 0.1 mM) (40). An ER-mediated mechanism
could still contribute to the long-term cardioprotective
effect of this phytoestrogen in vivo (13). Recently an
estrogen receptor-beta (ERbeta) was identified in rat pros-
tate tissue (42). This receptor has also been identified in
vascular tissue and may be responsible for some vascular
effects of estrogen. Similar effects are possible for phy-
toestrogens (43). In our experiments a steroid receptor-
mediated effect through ERbeta cannot be excluded.
Activation or inhibition of potassium channel activity in
arterial smooth muscle membrane contributes to regulation
of membrane potential and provides an important mecha-
nism involved in dilatation or constriction of arteries (44).
In our study, incubation with the ATP-sensitive potassium
channel blocker glibenclamide (45) and the nonspecific
potassium channel blocker barium chloride did not affect
genistein-induced relaxation, which suggests that potassium
channels do not play a role in this relaxation. However the
significance of these results may be limited by the fact that
the rings were precontracted with potassium chloride.
The demonstration of relaxing effects of genistein in
coronary arteries may have important implications in pa-
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tients with coronary artery disease and myocardial ischemia.
Being a non-sex steroidal estrogen, the benefits in the
vascular system may be achieved without significant sexual
effects. Genistein shares other cardiovascular beneficial ac-
tions with estrogen. The effects of genistein are tissue-
specific, with estrogen agonist effects on plasma lipid con-
centrations, plasma lipoprotein concentrations (46,47) and
preservation of bone mass (48,49) that are similar in
magnitude to mammalian estrogens but without estrogenic
effects on the uterus at these same doses (50,51). They may
also confer cardiovascular protection to women after meno-
pause, without the associated increased risk of uterine and
breast cancer that are associated with estrogen administra-
tion. The lack of sex effects, as well as the lack of difference
in response between coronary arteries from men and
women, means that the benefits conferred by genistein may
potentially apply to men.
Conclusions. We have shown that the phytoestrogens
genistein, phloretin, biochanin A and zearalanone induce
significant endothelium-independent relaxation in isolated
rabbit coronary arteries, which is independent of sex and of
the classical estrogen receptor. An important aspect of this
work is that the concentrations that have been shown to
induce coronary artery relaxation are in the same range as
the plasma concentrations of phytoestrogens measured in
the plasma of volunteers taking a commercially available soy
protein drink, namely Supro. The relaxation induced by
genistein is neither mediated by release of vasodilator,
prostanoids or cyclic GMP. ATP-sensitive potassium chan-
nels are probably not involved in the mechanism of
genistein-induced relaxation. The mechanism may involve
calcium-antagonism as observed for genistein and zearal-
anone and proven with electrophysiological experiments in
isolated myocytes for genistein. The demonstrated vasore-
laxation of coronary arteries induced by phytoestrogens may
be an important finding, as the mechanism involved in the
relaxing response may be linked to the decreased cardiovas-
cular risk in populations with high dietary phytoestrogen
intake.
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